CDC en Español


Group B Strep Prevention (GBS, baby strep, Group B streptococcal bacteria)

Home > Hospitals and Healthcare Providers > Resources > Reading

Hospitals and Healthcare Providers

Reading Resources

Publications from CDC

On this page:
MMWR articles
Surveillance articles
Prevention implementation studies
Neonatal sepsis trends
Review articles

MMWR Articles


  • Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrision LH, Lefkowitz LB, Hadler JL, Danilla R, Cieslak PR, Schuchat A. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15-20.
  • Whitney CG, Plikaytis BD, Gozansky WS, Wenger JD, Schuchat A. Prevention practices for perinatal group B streptococcal disease: a multi-state surveillance analysis. Obstet Gynecol 1997;89:28-32.


Applied Research

  • Schrag, SJ, Zell, ER, Lynfield, R , Roome, A., Arnold, KE, Craig, AS et al. 2002. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 347: 233-9.
  • Factor S, Levine OS, Nasser A, Potter J, Fajardo A, O’Sullivan MJ, Schuchat A. Impact of a risk-based prevention policy on neonatal group B streptococcal disease. Am J Obstet Gynecol 1998;179:1568-71.
  • Rosenstein N, Schuchat A. Opportunities for prevention of perinatal group B streptococcal disease: a multi state surveillance analysis. Obstet Gynecol 1997; 90:901-906.
  • Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811-815.


Prevention Implementation

  • Schuchat A, Roome A, Zell E, Linardos H, Zywicki S, O'Brien KL. Integrated monitoring of a new group B streptococcal disease prevention program and other perinatal infections. Mat Child Health 2002;6: 107-14.
  • Watt JP, Schuchat A, Erickson K, Honig JE, Gibbs R, Schulkin J. Group B streptococcal disease prevention practices of obstetrician-gynecologists. Obstet Gynecol 2001;98:7-13.
  • Schrag SJ, Whitney CG, Schuchat A. Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts. Infect Control Hosp Epidemiol 2000; 21(7): 473-483.
  • Preventing neonatal group B streptococcal disease: the role of the clinical microbiology laboratory. Clin Microbiol Newsletter 1997; 19(15):113-116.


Neonatal Sepsis Trends

  • Hyde TB, Hilger TM, Reingold A, Farley MM, O'Brien KL, Schuchat A. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. Pediatrics 2002;110(4):690-5.
  • Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001;108:1094-1098.
  • Schuchat A, Zywicki S, Dinsmoor MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study. Pediatrics 2000;105:21-26.



  • Schuchat A. Group B streptococcus. Lancet 1999;353:51-6.
  • Schuchat A. Epidemiology of group B streptococcal disease in the United States: Shifting paradigms. Clin Microbiol Rev 1998;11:497-513.

Page Last Modified: April 20, 2008
Content Last Reviewed: April 20, 2008
Content Source: National Center for Immunization and Respiratory Diseases
  • Email this page

Contact CDC

English and Spanish
(800) CDC-INFO
(800) 232-4636
TTY: (888) 232-6348
FAX: (770) 488-4760

International Travel
Phone: 1-887-394-8747

Safer Healthier People

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Public Inquiries: 1-800-CDC-INFO (232-4636) / 1-888-232-6348 (TTY)